COLLINS MEDICAL LIMITED

Company Registration Number:
15874737 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2025

Period of accounts

Start date: 3 August 2024

End date: 31 August 2025

COLLINS MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 August 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

COLLINS MEDICAL LIMITED

Directors' report period ended 31 August 2025

The directors present their report with the financial statements of the company for the period ended 31 August 2025

Principal activities of the company

Manufacture of medical and dental instruments and supplies



Directors

The director shown below has held office during the whole of the period from
3 August 2024 to 31 August 2025

Adrian John Gee-Turner


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
1 May 2026

And signed on behalf of the board by:
Name: Adrian John Gee-Turner
Status: Director

COLLINS MEDICAL LIMITED

Profit And Loss Account

for the Period Ended 31 August 2025

13 months to 31 August 2025


£
Turnover: 33,770
Cost of sales: ( 1,013 )
Gross profit(or loss): 32,757
Administrative expenses: ( 81,447 )
Operating profit(or loss): (48,690)
Profit(or loss) before tax: (48,690)
Profit(or loss) for the financial year: (48,690)

COLLINS MEDICAL LIMITED

Balance sheet

As at 31 August 2025

Notes 13 months to 31 August 2025


£
Current assets
Debtors: 3 13,864
Cash at bank and in hand: 2,252
Total current assets: 16,116
Creditors: amounts falling due within one year: 4 ( 64,707 )
Net current assets (liabilities): (48,591)
Total assets less current liabilities: (48,591)
Total net assets (liabilities): (48,591)
Capital and reserves
Called up share capital: 100
Profit and loss account: (48,691 )
Total Shareholders' funds: ( 48,591 )

The notes form part of these financial statements

COLLINS MEDICAL LIMITED

Balance sheet statements

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 May 2026
and signed on behalf of the board by:

Name: Adrian John Gee-Turner
Status: Director

The notes form part of these financial statements

COLLINS MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

COLLINS MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 2. Employees

    13 months to 31 August 2025
    Average number of employees during the period 0

COLLINS MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2025

3. Debtors

13 months to 31 August 2025
£
Trade debtors 4,167
Other debtors 9,697
Total 13,864

COLLINS MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2025

4. Creditors: amounts falling due within one year note

13 months to 31 August 2025
£
Trade creditors 26,487
Other creditors 38,220
Total 64,707